Dr. Charmian A Quigley MD
Endocronologist (Pediatric) | Pediatric Endocrinology
702 Barnhill Dr Ri 5960 Indianapolis IN, 46202About
Dr. Charmian Quigley is a pediatric endocrinologist practicing in Indianapolis, IN. Dr. Quigley specializes in growth, puberty, diabetes or other disorders related to hormones that produce certain conditions in children and growing young adults. Pediatric endocrinologists possess copious knowledge on hormone chemicals and how they can affect other parts of the body and their functions.
Education and Training
Univ of New South Wales, Fac of Med, Kensington, Nsw, Australia 1979
University Of New South Wales Sydney Australia 1979
University of New South Wales Faculty of Medicine 1979
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Editorial: The postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome.
- Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
- Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study.
- Massive ischemic intestinal necrosis at the onset of diabetes mellitus with ketoacidosis in a three-year-old girl.
- Ascertainment bias in Turner syndrome: new insights from girls who were diagnosed incidentally in prenatal life.
- Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
- Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss.
- Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age.
- Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
- Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency.
- Growth hormone treatment of non-growth hormone-deficient growth disorders.
- Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
- Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
- Fingers as a marker of prenatal androgen exposure.
- Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome.
Dr. Charmian A Quigley MD's Practice location
INDIANAPOLIS, IN 46202Get Direction
Dr. Charmian A Quigley MD's reviews
Write ReviewRecommended Articles
- What is Apert Syndrome?
Apert syndrome, named after the French physician who described the condition for the first time, is a genetic disorder characterized by several birth defects. Children with this syndrome will have an abnormally developed face and skull. This syndrome is rare and in most cases, it develops even when...
- Celiac Disease May Shadow Type 1 Diabetes
A recent study has found that celiac disease may follow Type 1 diabetes, and it has found that children have a greater risk of having celiac disease auto-antibodies, which may then result in the disorder.According to Dr. William Hagopian, type 1 diabetes and celiac disease are closely related...
- What Is Metabolism?
IntroductionMetabolism is a complex biochemical process that is needed to maintain life. Availability of nutrients and nutrition are closely associated with metabolism since metabolism is a process that involves the conversion of food into energy, which is used to fuel the body's cells. The basal...
- Pre-digested Formula May Reduce the Risk of Type 1 Diabetes in Infants
A new study has shown that pre-digested formula may reduce the risk of Type 1 diabetes in infants who have a high risk for developing this condition. The study reports that babies who were fed on pre-digested formula had a 50% lower chance of developing the kind of antibodies that predict diabetes,...
- Diabetes vs. Science: Who’s Winning?
What Is Diabetes?Diabetes is a serious chronic illness that could affect 552 million people by the year 2030, according to the International Diabetes Federation (IDF). A person suffering from diabetes is at a much greater risk of heart attack, kidney damage, or stroke. Therefore, we are now putting...
- Glucose Monitor May Eliminate Need for Finger Stick
A novel system that has already been approved has a revolutionary technology to monitor blood sugar levels. It works with a small sensor that is placed on the arm of the person being monitored and gives reports minute by minute.Glucose monitoring is something that people with diabetes should do...
Nearby Providers
- Dr. Nadine G. Haddad MD705 Riley Hospital Dr Indianapolis IN 46202
- Dr. Emily C. Walvoord MD705 Riley Hospital Dr Indianapolis IN 46202
- Dr. Zeina M. Nabhan MD705 Riley Hospital Dr Indianapolis IN 46202
- Dr. Susanne Marie Cabrera M.D.702 Barnhill Drive Indianapolis IN 46202
- Dr. Erica A Eugster MD705 Riley Hospital Dr Indianapolis IN 46202
- Dr. Todd David Nebesio M.D.705 Riley Hospital Dr Indianapolis IN 46202